Abiopharma

(80% Positive) OPORTUN FINANCIAL CORP (OPRT) Files Form 8-K

Annovis Secures U.S. Patent for Buntanetap in the Prevention and Treatment of Neurological Injuries Caused by Brain Infections

MiNK Therapeutics to Present New Data at ASGCT 2026 Highlighting Context-Dependent Activity of iNKT Cell Therapy

V2X Names Mike Uster Chief Information Officer to Advance Enterprise Technology Strategy

Lincoln Electric Schedules Webcast for First Quarter 2026 Results

Plus Therapeutics Secures Highmark Coverage for CNSide® CSF Assay, Expanding Reimbursement to ~75 Million Covered Lives

Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer

Soluna Closes $53M Briscoe Wind Farm Acquisition; Achieves Vertical Integration

General Announcement: Drilling programme in Yumna Field, Oman now expected to start in May 2026

General Announcement: Share Transaction of Person Discharging Managerial Responsibilities

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001193125-26-139267 <b>Size:</b> 239 KB

New Form 424B2 - TORONTO DOMINION BANK <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001140361-26-012911 <b>Size:</b> 547 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001918704-26-009100 <b>Size:</b> 972 KB

NAMIB MINERALS (NAMMW) Files Form 6-K

New Form 424B2 - UBS AG <b>Filed:</b> 2026-04-02 <b>AccNo:</b> 0001839882-26-018808 <b>Size:</b> 493 KB